{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:02:26Z","timestamp":1761930146508,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010076","name":"Chicago State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijpddr.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T21:43:01Z","timestamp":1598305381000},"page":"80-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Novel acyl carbamates and acyl \/ diacyl ureas show in vitro efficacy against Toxoplasma gondii and Cryptosporidium parvum"],"prefix":"10.1016","volume":"14","author":[{"given":"Kun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Grooms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6239-9446","authenticated-orcid":false,"given":"Shahbaz M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anolan Garcia","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Witola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5750-358X","authenticated-orcid":false,"given":"Jozef","family":"Stec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2020.08.006_bib1","first-page":"441","article-title":"Complete genome sequence of apicomplexan","volume":"304","author":"Abrahamsen","year":"2004","journal-title":"C. parvum. Science."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2125.2007.02873.x","article-title":"Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis","volume":"63","author":"Abubakar","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/AAC.35.2.293","article-title":"Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii","volume":"35","author":"Araujo","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2307\/3282084","article-title":"Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients","volume":"73","author":"Arrowood","year":"1987","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib6","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1128\/AAC.02541-14","article-title":"Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica","volume":"58","author":"Boyom","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"author":"Centers for Disease Control and Prevention Cdc","key":"10.1016\/j.ijpddr.2020.08.006_bib7"},{"author":"Centers for Disease Control and Prevention Cdc","key":"10.1016\/j.ijpddr.2020.08.006_bib8"},{"key":"10.1016\/j.ijpddr.2020.08.006_bib9","series-title":"Microbiology of Waterborne Diseases","first-page":"287","article-title":"Cryptosporidium","author":"Chalmers","year":"2014"},{"key":"10.1016\/j.ijpddr.2020.08.006_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","article-title":"A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for Cryptosporidium","volume":"15","author":"Checkley","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib11","series-title":"Cryptosporidiosis of Man and Animals","first-page":"44","article-title":"Techniques and laboratory maintenance of Cryptopsoridium, p 44-77","author":"Current","year":"1992"},{"key":"10.1016\/j.ijpddr.2020.08.006_bib12","doi-asserted-by":"crossref","first-page":"103467","DOI":"10.1016\/j.bioorg.2019.103467","article-title":"Synthesis, in vitro and in vivo biological evaluation of dihydroartemisinin derivatives with potential anti-Toxoplasma gondii agents","volume":"94","author":"Deng","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib13","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1128\/AAC.00207-08","article-title":"Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model","volume":"52","author":"Downey","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib14","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/AAC.06450-11","article-title":"Unique parasite secretory pathway disrupted by novel hydroxybenzamides,","volume":"56","author":"Fomovska","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/0974-777X.83536","article-title":"Toxoplasmosis: a global threat","volume":"3","author":"Furtado","year":"2011","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib16","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1055\/s-0036-1588724","article-title":"Convenient one-pot two-step synthesis of symmetrical and unsymmetrical diacyl ureas, acyl urea\/carbamate\/thiocarbamate derivatives, and related compounds","volume":"49","author":"Garcia Hernandez","year":"2017","journal-title":"Synthesis"},{"key":"10.1016\/j.ijpddr.2020.08.006_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/46.1.57","article-title":"Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells","volume":"46","author":"Gargala","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nchembio.794","article-title":"Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane","volume":"8","author":"Grzegorzewicz","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.47.1.309-316.2003","article-title":"High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein","volume":"47","author":"Gubbels","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib20","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1021\/acs.jafc.9b02173","article-title":"Synthesis and biological evaluation of (+)-Usnic acid derivatives as potential anti-Toxoplasma gondii agents","volume":"67","author":"Guo","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib21","doi-asserted-by":"crossref","first-page":"R770","DOI":"10.1016\/j.cub.2018.05.035","article-title":"Toxoplasma gondii","volume":"28","author":"Kochanowsky","year":"2018","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib22","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.bmcl.2012.12.024","article-title":"Tryptanthrin derivatives as Toxoplasma gondii inhibitors \u2013 structure-activity-relationship of the 6-position","volume":"23","author":"Krivogorsky","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ijpddr.2020.08.006_bib23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/AAC.01915-15","article-title":"Inhibition of Calcium-Dependent Protein Kinase 1 (CDPK1) in vitro by pyrazolopyrimidine derivatives does not correlate with sensitivity of Cryptosporidium parvum growth in cell culture","volume":"60","author":"Kuhlenschmidt","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007953","article-title":"Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum","volume":"15","author":"Li","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14756366.2019.1584622","article-title":"Synthesis and biological evaluation of ursolic acid derivatives bearing triazole moieties as potential anti-Toxoplasma gondii agents","volume":"344","author":"Luan","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.parint.2009.08.004","article-title":"Thiolactomycin analogues as potential anti-Toxoplasma gondii agents","volume":"58","author":"Martins-Duarte","year":"2009","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fpubh.2019.00025","article-title":"Mortality patterns of toxoplasmosis and its comorbidities in Tanzania: a 10-year retrospective hospital-based survey","volume":"7","author":"Mboera","year":"2019","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ijpddr.2020.08.006_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.inf.0000202070.59190.9a","article-title":"Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis","volume":"25","author":"McLeod","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib29","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.22572","article-title":"Effect of propranolol alone and in combination with pyrimethamine on acute murine toxoplasmosis","volume":"8","author":"Montazeri","year":"2015","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib31","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dki319","article-title":"Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines","volume":"56","author":"Protopopova","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1179\/2047773213Y.0000000094","article-title":"Antibiotics for human toxoplasmosis: asystematic review of randomized trials","volume":"107","author":"Rajapakse","year":"2013","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.ijpddr.2020.08.006_bib33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ijpara.2017.05.002","article-title":"Targeted gene knockdown validates the essential role of lactate dehydrogenase in Cryptosporidium parvum","volume":"47","author":"Witola","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejmech.2018.08.087","article-title":"Synthesis and evaluation of novel arctigenin derivatives as potential anti-Toxoplasma gondii agents","volume":"158","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2020.08.006_bib35","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/AAC.02225-13","article-title":"Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:52:31Z","timestamp":1761922351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320720300269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":34,"alternative-id":["S2211320720300269"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.08.006","relation":{},"ISSN":["2211-3207"],"issn-type":[{"type":"print","value":"2211-3207"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel acyl carbamates and acyl \/ diacyl ureas show in vitro efficacy against Toxoplasma gondii and Cryptosporidium parvum","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}